Sonnet BioTherapeutics Holdings, Inc. short interest in 2022
In 2022, Sonnet BioTherapeutics Holdings, Inc.'s disclosed short interest ran from 0.47% of shares outstanding on 14 Jan 2022 to 0.99% on 15 Sep 2022, a change of +0.52 percentage points. The year's high was 3.52% on 15 Jun 2022 and its low 0.39% on 31 Jan 2022, averaging 1.13% across 9 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.76 days on 31 May 2022. Full history: Sonnet BioTherapeutics Holdings, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 0.47% (14 Jan 2022)
- End of year
- 0.99% (15 Sep 2022)
- Change
- +0.52 pp
- High
- 3.52% (15 Jun 2022)
- Low
- 0.39% (31 Jan 2022)
- Average
- 1.13%
- Highest days to cover
- 1.76 (31 May 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 0.47% | 1.00 | |
| 31 Jan 2022 | 0.39% | 1.00 | |
| 15 Mar 2022 | 0.81% | 1.00 | 10-Q filed, results (8-K) |
| 13 May 2022 | 1.43% | 1.07 | 10-Q filed, results (8-K) |
| 31 May 2022 | 1.58% | 1.76 | |
| 15 Jun 2022 | 3.52% | 1.00 | |
| 15 Aug 2022 | 0.39% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 0.60% | 1.00 | |
| 15 Sep 2022 | 0.99% | 1.00 |
See also: Sonnet BioTherapeutics Holdings, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.